Monday, April 24, 2017 4:29:13 PM
No excessive shorting is happening with this ticker. The daily reports indicate typical averages for penny stocks.
http://otcshortreport.com/?index=VDRM&action=view
There is no record of a Kasten trade halt by the SEC. The company may have chosen to cease trading while they work through their transition with Dakota Life Sciences. Keough did note the merger was at risk of dissolution as a result of Otiko's actions, and institutional investor fears related to Otiko's actions.
Fundamentals are horrible here. They may have to raise the Authorized so they can sell more shares to cover legal fees. The A/S is only 60M above the O/S. They reported a Going Concern with a delinquent Note in the 200-300K area. This is no "boilerplate" verbiage. It has a real number. Some tickers express NO going concern. Otiko owes ViaDerma 300k according to the latest financial report. That number is in the A/R line.
Now Otiko is facing the possibility of an injunction to prevent him from selling products based on IP owned by Keough.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM